The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021

被引：0
|
作者：
Chen Li
Jun Hao
Yitian Zheng
Chuangshi Wang
Jie Yang
Wenyao Wang
Kuo Zhang
Chunli Shao
Wen Hui
Jiancheng Wang
Wei Li
Yi-Da Tang
机构：
[1] Chinese Academy of Medical Sciences,Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College
[2] National Clinical Research Center for Cardiovascular Diseases,Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College
[3] Chinese Academy of Medical Sciences,Department of Cardiology, Institute of Vascular Medicine, Key Laboratory of Molecular Cardiovascular Science
[4] Peking University Third Hospital,Department of Science and Technology, West China Hospital
[5] Ministry of Education,Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences
[6] Sichuan University,Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases
[7] Peking University,undefined
[8] Chinese Academy of Medical Sciences,undefined
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
Cardiometabolic disease; China; Drug clinical trial; Changing landscape;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Changing Landscape and Disease-specific Considerations of Therapeutic Bronchoscopy in Clinical Trials
    Gildea, Thomas R.
    Mehra, Reena
    [J]. JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, 2014, 21 (01) : 1 - 5
  • [22] Analysis of Suspension of Clinical Trials for Drug Registration in China
    Su, Xian
    Pang, Xiaocong
    Zeng, Xin
    Gao, Yi
    Cui, Yimin
    Wang, Haixue
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [23] Clinical trials and drug approvals continue to accelerate in China
    Wang, Mai
    [J]. LANCET ONCOLOGY, 2017, 18 (07): : 855 - 855
  • [24] Priorities of clinical drug trials in Brazil and neglected diseases of poverty
    Santana, Rafael Santos
    Leite, Silvana Nair
    [J]. REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 40 (05): : 356 - 362
  • [25] Analysis of Clinical Trials of New Drugs for Liver Diseases in China
    Lin, Longfei
    Li, Hui
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3181 - 3191
  • [26] Evolving drug regulatory landscape in China: A clinical pharmacology perspective
    Tang, Weifeng
    Huang, Ying
    Zhou, Diansong
    Huang, Yao
    Chen, Yingxue
    Ren, Song
    Li, Yan
    Wu, Shengqian
    Zhao, Xiaoying
    Song, Xuyang
    Wang, Haidong
    Jin, Yuwen
    Yu, Hongtao
    Zhang, Li
    Li, Yunfei
    Boulton, David
    Shen, Kevin
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1222 - 1230
  • [27] The changing landscape of cancer cell therapies: clinical trials and real-world data
    Saez-Ibanez, Ana Rosa
    Upadhaya, Samik
    Partridge, Tanya
    Winkelman, Daniel
    Correa, Diego
    Campbell, Jay
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (10) : 736 - 737
  • [28] Oscillatory properties of class C notifiable infectious diseases in China from 2009 to 2021
    Cao, Yanxiang
    Li, Meijia
    Haihambo, Naem
    Zhu, Yuyao
    Zeng, Yimeng
    Jin, Jianhua
    Qiu, Jinyi
    Li, Zhirui
    Liu, Jiaxin
    Teng, Jiayi
    Li, Sixiao
    Zhao, Yanan
    Zhao, Xixi
    Wang, Xuemei
    Li, Yaqiong
    Feng, Xiaoyang
    Han, Chuanliang
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [29] Mapping the cell therapy landscape: insights into clinical trials and regulatory advances in China
    Du, Xin
    Luo, Xingxian
    Liu, Lanqiu
    Cao, Yanlin
    Zhang, Yajuan
    Zhang, Yi
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [30] The changing landscape of urologic oncology: Initiating systemic therapies, interventional skills, and clinical trials Introduction
    Lin, Daniel W.
    Shore, Neal D.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : S1 - S1
12345